CONCERT PHARMACEUTICALS, INC.
CONCERT PHARMACEUTICALS, INC. (CNCE) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 374 transactions totaling $97.9M, demonstrating a bearish sentiment with -$47.5M in net insider flow. The most recent transaction on Mar 6, 2023 involved a transaction of 342,100 shares valued at $0.
CNCE Insider Activity Summary
Who Is Buying CNCE Stock?
No significant insider buying has been recorded for CNCE in the recent period.
Who Is Selling CNCE Stock?
No significant insider selling has been recorded for CNCE in the recent period.
Is CONCERT PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CNCE is bearish with an Insider Alignment Score of 26/100 and a net flow of -$47.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CNCE Frequently Asked Questions
Understanding CNCE Insider Activity
Insider trading at CONCERT PHARMACEUTICALS, INC. (CNCE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading CNCE stock, having executed 374 transactions in the past 90 days. The most active insider is Value Fund L. P. Biotechnology (Executive), who has made 6 transactions totaling $38.3M.
Related Tools
Track CONCERT PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at CNCE file new Form 4 transactions